An experimental chemotherapy kills leukemia cells that are abundant in proteins critical to cancer growth, according to new research from Weill Cornell Medicine.
Cornell researchers investigating why HA treatments have produced mixed results discovered that a molecule, lubricin, helps anchor HA at the tissue surface, which helps to move cartilage into a low-friction regime.
Cornell researchers will travel to Paris as part of the university's delegation to the global climate change summit, COP21. Delegations from over 190 countries and more than 50,000 people will attend.
Cornell researchers from the Food and Brand Lab have found that men eat significantly more food when in the company of women, suggesting a hardwired male urge to demonstrate prowess.
A discovery by Weill Cornell Medicine investigators may settle a longstanding debate about how cancers spread, the investigators say, and may change the way many forms of the disease are treated.
Weill Cornell Medicine has entered into an agreement with Top Spring Huaxia Medical Investment to help it develop a modern outpatient diagnostic clinic in Shenzhen, China.
New Cornell research published online Nov. 9 in Nature Cell Biology describes a system that controls levels of a cell's sensors, which are responsible for detecting the accumulation of misfolded proteins.
Cornell biomedical engineers have developed specialized white blood cells – dubbed "super natural killer cells" – that seek out cancer cells in lymph nodes with only one purpose: destroy them.
As many as one out of 10 people age 60 and older will experience some kind of abuse, most often in the form of financial exploitation, says a new Cornell study.
